Complementary and Alternative Medicine Use in Individuals Presenting for Care at a Comprehensive Cancer Center

Por Judson, Patricia L., Abdallah, Reem, Xiong, Yin, Ebbert, Judith, Lancaster, Johnathan M.
Publicado no Integr Cancer Ther (2016)

Oncology Healthcare Providers’ Knowledge, Attitudes, and Practice Behaviors Regarding LGBT Health

Por Shetty, Gina, Sanchez, Julian A., Lancaster, Johnathan M., Wilson, Lauren E., Quinn, Gwendolyn P., Schabath, Matthew B.
Publicado no Patient Educ Couns (2016)

Molecular determinants for lymph node metastasis in clinically early-stage endometrial cancer

Por BOU ZGHEIB, NADIM, MARCHION, DOUGLAS C., BUSH, STEPHEN H., JUDSON, PATRICIA L., WENHAM, ROBERT M., APTE, SACHIN M., LANCASTER, JOHNATHAN M., GONZALEZ-BOSQUET, JESUS
Publicado no Oncol Lett (2016)

STAT3 polymorphisms may predict an unfavorable response to first-line platinum-based therapy for women with advanced serous epithelial ovarian cancer

Por Permuth-Wey, Jennifer, Fulp, William J., Reid, Brett M., Chen, Zhihua, Georgeades, Christina, Cheng, Jin Q., Magliocco, Anthony, Chen, Dung-Tsa, Lancaster, Johnathan M.
Publicado no Int J Cancer (2015)

Fascin Protein Is Critical for Transforming Growth Factor β Protein-induced Invasion and Filopodia Formation in Spindle-shaped Tumor Cells

Por Sun, Jianwei, He, Huifang, Xiong, Yin, Lu, Shuang, Shen, Junling, Cheng, Anna, Chang, Wei-Chiao, Hou, Ming-Feng, Lancaster, Johnathan M., Kim, Minjung, Yang, Shengyu
Publicado em 2011

Evaluation of the 12-Gene Molecular Score and the 21-Gene Recurrence Score as Predictors of Response to Neo-adjuvant Chemotherapy in Estrogen Receptor-Positive, HER2-Negative Breas...

Por Soliman, Hatem, Wagner, Susanne, Flake, Darl D., Robson, Mark, Schwartzberg, Lee, Sharma, Priyanka, Magliocco, Anthony, Kronenwett, Ralf, Lancaster, Johnathan M., Lanchbury, Jerry S., Gutin, Alexander, Gradishar, William
Publicado no Ann Surg Oncol (2020)

Modes of Delivery of Genetic Testing Services and the Uptake of Cancer Risk Management Strategies in BRCA1 and BRCA2 Carriers

Por Pal, Tuya, Lee, Ji-Hyun, Besharat, Andrea, Thompson, Zachary, Monteiro, Alvaro N.A., Phelan, Catherine, Lancaster, Johnathan M., Metcalfe, Kelly, Sellers, Thomas A., Vadaparampil, Susan, Narod, Steven A.
Publicado no Clin Genet (2013)

MicroRNA MiR-214 Regulates Ovarian Cancer Cell Stemness by Targeting p53/Nanog

Por Xu, Cheng-Xiong, Xu, Meng, Tan, Lei, Yang, Hua, Permuth-Wey, Jennifer, Kruk, Patricia A., Wenham, Robert M., Nicosia, Santo V., Lancaster, Johnathan M., Sellers, Thomas A., Cheng, Jin Q.
Publicado em 2012

MicroRNA MiR-214 regulates ovarian cancer cell stemness by targeting p53/Nanog.

Por Xu, Cheng-Xiong, Xu, Meng, Tan, Lei, Yang, Hua, Permuth-Wey, Jennifer, Kruk, Patricia A., Wenham, Robert M., Nicosia, Santo V., Lancaster, Johnathan M., Sellers, Thomas A., Cheng, Jin Q.
Publicado no J Biol Chem (2016)

BCL2 antagonist of cell death kinases, phosphatases, and ovarian cancer sensitivity to cisplatin

Por Bansal, Nisha, Marchion, Douglas C., Bicaku, Elona, Xiong, Yin, Chen, Ning, Stickles, Xiaomang B., Sawah, Entidhar Al, Wenham, Robert M., Apte, Sachin M., Gonzalez-Bosquet, Jesus, Judson, Patricia L., Hakam, Ardeshir, Lancaster, Johnathan M.
Publicado em 2012

Human cancer cell line microRNAs associated with in vitro sensitivity to paclitaxel

Por CHEN, NING, CHON, HYE SOOK, XIONG, YIN, MARCHION, DOUGLAS C., JUDSON, PATRICIA L., HAKAM, ARDESHIR, GONZALEZ-BOSQUET, JESUS, PERMUTH-WEY, JENNIFER, WENHAM, ROBERT M., APTE, SACHIN M., CHENG, JIN Q., SELLERS, THOMAS A., LANCASTER, JOHNATHAN M.
Publicado em 2014

Characterizing the efficacy of fermented wheat germ extract against ovarian cancer and defining the genomic basis of its activity

Por Judson, Patricia L., Al Sawah, Entidhar D., Marchion, Douglas C., Xiong, Yin, Bicaku, Elona, Zgheib, Nadim Bou, Chon, Hye Sook, Stickles, Xiaomang B., Hakam, Ardeshir, Wenham, Robert M., Apte, Sachin M., Gonzalez-Bosquet, Jesus, Lancaster, Johnathan M.
Publicado em 2012

A novel c-Met inhibitor, MK8033, synergizes with carboplatin plus paclitaxel to inhibit ovarian cancer cell growth

Por MARCHION, DOUGLAS C., BICAKU, ELONA, XIONG, YIN, ZGHEIB, NADIM BOU, SAWAH, ENTIDHAR AL, STICKLES, XIAOMANG BA, JUDSON, PATRICIA L., LOPEZ, ALEX S., CUBITT, CHRISTOPHER L., GONZALEZ-BOSQUET, JESUS, WENHAM, ROBERT M., APTE, SACHIN M., BERGLUND, ANDERS, LANCASTER, JOHNATHAN M.
Publicado no Oncol Rep (2013)

Microarray analysis of early stage serous ovarian cancers demonstrates profiles predictive of favorable outcome

Por Berchuck, Andrew, Iversen, Edwin S., Luo, Jingqin, Clarke, Jennifer P., Horne, Hisani, Levine, Douglas A., Boyd, Jeff, Alonso, Miguel A., Secord, Angeles Alvarez, Bernardini, Marcus Q., Barnett, Jason C, Boren, Todd, Murphy, Susan K., Dressman, Holly K., Marks, Jeffrey R., Lancaster, Johnathan M.
Publicado em 2009

Gene expression data reveal common pathways that characterize the unifocal nature of ovarian cancer

Por MARCHION, Douglas C., XIONG, Yin, CHON, Hye Sook, SAWAH, Entidhar AL, ZGHEIB, Nadim BOU, RAMIREZ, Ingrid J., ABBASI, Forough, STICKLES, Xiaomang B., JUDSON, Patricia L., HAKAM, Ardeshir, GONZALEZ-BOSQUET, Jesus, WENHAM, Robert M., APTE, Sachin M., BERGLUND, Anders E., LANCASTER, Johnathan M.
Publicado em 2013

The O-glycan pathway is associated with in vitro sensitivity to gemcitabine and overall survival from ovarian cancer

Por ZGHEIB, NADIM BOU, XIONG, YIN, MARCHION, DOUGLAS C., BICAKU, ELONA, CHON, HYE SOOK, STICKLES, XIAOMANG BA, AL SAWAH, ENTIDHAR, JUDSON, PATRICIA L., HAKAM, ARDESHIR, GONZALEZ-BOSQUET, JESUS, WENHAM, ROBERT M., APTE, SACHIN M., CUBITT, CHRISTOPHER L., CHEN, DUNG TSA, LANCASTER, JOHNATHAN M.
Publicado em 2012

BAD-mediated apoptotic pathway is associated with human cancer development

Por STICKLES, XIAOMANG B, MARCHION, DOUGLAS C, BICAKU, ELONA, SAWAH, ENTIDHAR AL, ABBASI, FOROUGH, XIONG, YIN, ZGHEIB, NADIM BOU, BOAC, BERNADETTE M, ORR, BRIAN C, JUDSON, PATRICIA L, BERRY, AMY, HAKAM, ARDESHIR, WENHAM, ROBERT M, APTE, SACHIN M, BERGLUND, ANDERS E, LANCASTER, JOHNATHAN M
Publicado no Int J Mol Med (2015)

Sensitivity of ovarian cancer cells to acetaminophen reveals biological pathways that affect patient survival

Por BUSH, STEPHEN H., TOLLIN, SHARON, MARCHION, DOUGLAS C., XIONG, YIN, ABBASI, FOROUGH, RAMIREZ, INGRID J., ZGHEIB, NADIM BOU, BOAC, BERNADETTE, JUDSON, PATRICIA L., CHON, HYE SOOK, WENHAM, ROBERT M., APTE, SACHIN M., CUBITT, CHRISTOPHER L., BERGLUND, ANDERS E., HAVRILESKY, LAURA J., LANCASTER, JOHNATHAN M.
Publicado no Mol Clin Oncol (2016)

Micro-RNAs associated with the evolution of ovarian cancer cisplatin resistance

Por Boac, Bernadette M., Xiong, Yin, Marchion, Douglas C., Abbasi, Forough, Bush, Stephen H., Ramirez, Ingrid J., Khulpateea, Beman R., McClung, E. Clair, Berry, Amy L., Zgheib, Nadim Bou, Chon, Hye Sook, Shahzad, Mian M., Judson, Patricia L., Wenham, Robert M., Apte, Sachin M., Berglund, Anders E., Magliocco, Anthony M., Lancaster, Johnathan M.
Publicado no Gynecol Oncol (2015)

Expression of the BAD pathway is a marker of triple-negative status and poor outcome

Por Boac, Bernadette M., Abbasi, Forough, Ismail-Khan, Roohi, Xiong, Yin, Siddique, Atif, Park, Hannah, Han, Mingda, Saeed-Vafa, Daryoush, Soliman, Hatem, Henry, Brendon, Pena, M. Juliana, McClung, E. Clair, Robertson, Sharon E., Todd, Sarah L., Lopez, Alex, Sun, Weihong, Apuri, Susmitha, Lancaster, Johnathan M., Berglund, Anders E., Magliocco, Anthony M., Marchion, Douglas C.
Publicado no Sci Rep (2019)